Phase 2 Study of CU104 in Moderate-Severe Ulcerative Colitis

Clinical trial NCT05907330 · UNKNOWN

Trial details

NCT number: NCT05907330
Sponsor: Curacle Co., Ltd.
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2024-06-01
Primary completion: 2026-02-28
Enrollment: 45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.